Zhang Claire Shuiqing, Tan Hsiewe Ying, Zhang George Shengxi, Zhang Anthony Lin, Xue Charlie Changli, Xie Yi Min
Traditional and Complementary Medicine Research Program, RMIT Health Innovations Research Institute, School of Health Sciences, RMIT University, Bundoora, Victoria, Australia.
Centre for Innovative Structures and Materials, School of Civil, Environmental and Chemical Engineering, RMIT University, Melbourne, Victoria, Australia.
PLoS One. 2015 Nov 4;10(11):e0140825. doi: 10.1371/journal.pone.0140825. eCollection 2015.
While the use of acupuncture has been recognised by the World Health Organisation, its efficacy for many of the common clinical conditions is still undergoing validation through randomised controlled trials (RCTs). A credible placebo control for such RCTs to enable meaningful evaluation of its efficacy is to be established. While several non-penetrating acupuncture placebo devices, namely the Streitberger, the Park and the Takakura Devices, have been developed and used in RCTs, their suitability as inert placebo controls needs to be rigorously determined. This article systematically reviews these devices as placebo interventions. Electronic searches were conducted on four English and two Chinese databases from their inceptions to July 2014; hand searches of relevant references were also conducted. RCTs, in English or Chinese language, comparing acupuncture with one of the aforementioned devices as the control intervention on human participants with any clinical condition and evaluating clinically related outcomes were included. Thirty-six studies were included for qualitative analysis while 14 were in the meta-analysis. The meta-analysis does not support the notion of either the Streitberger or the Park Device being inert control interventions while none of the studies involving the Takakura Device was included in the meta-analysis. Sixteen studies reported the occurrence of adverse events, with no significant difference between verum and placebo acupuncture. Author-reported blinding credibility showed that participant blinding was successful in most cases; however, when blinding index was calculated, only one study, which utilised the Park Device, seemed to have an ideal blinding scenario. Although the blinding index could not be calculated for the Takakura Device, it was the only device reported to enable practitioner blinding. There are limitations with each of the placebo devices and more rigorous studies are needed to further evaluate their effects and blinding credibility.
虽然针灸的使用已得到世界卫生组织的认可,但其对许多常见临床病症的疗效仍在通过随机对照试验(RCT)进行验证。需要建立一种可靠的安慰剂对照,以便在此类RCT中对其疗效进行有意义的评估。虽然已经开发出几种非穿透性针灸安慰剂装置,即施特赖特贝格装置、帕克装置和高仓装置,并在RCT中使用,但需要严格确定它们作为惰性安慰剂对照的适用性。本文系统评价了这些装置作为安慰剂干预措施的情况。对四个英文数据库和两个中文数据库从建库至2014年7月进行了电子检索;还对手头检索到的相关参考文献进行了检索。纳入了以英文或中文发表的RCT,这些研究将针灸与上述装置之一作为对照干预措施,用于患有任何临床病症的人类参与者,并评估临床相关结局。纳入36项研究进行定性分析,14项研究纳入荟萃分析。荟萃分析不支持施特赖特贝格装置或帕克装置作为惰性对照干预措施的观点,而涉及高仓装置的研究均未纳入荟萃分析。16项研究报告了不良事件的发生情况,真针灸和安慰剂针灸之间无显著差异。作者报告的盲法可信度表明,在大多数情况下参与者的盲法是成功的;然而,在计算盲法指数时,只有一项使用帕克装置的研究似乎具有理想的盲法情况。虽然无法计算高仓装置的盲法指数,但它是唯一报告能够实现从业者盲法的装置。每种安慰剂装置都有局限性,需要更严格的研究来进一步评估它们的效果和盲法可信度。